Podcasts

Behind the controversy is some common ground, buried deep in the DSM. New insights and podcast here.

Some dyskinesias improve with antipsychotic treatment, and these types are more common than thought. More in this podcast.

Bupropion is one of the better tolerated antidepressants, but concerns about anxiety, insomnia, and seizures have dampened its popularity. In this podcast, we’ll see how well those concerns hold up to the evidence.

Psyched! podcast hosts interview Carol A. Bernstein, MD, who makes the case for psychiatrists using their voice to help psychiatric patients and families.

Presenters of Psyched! podcast talk about biological psychiatry, schizophrenia, and biotypes with a researcher who has presented groundbreaking work in the field.

In this podcast, Dr Mark Komrad explores the relatively new Medical Aid in Dying (MAID) law in Canada, and how it may be on the verge of opening medical euthanasia to certain qualified psychiatric patients

A physician suicide loss survivor shares her story of grief after losing her husband as well as her experience telling her 3 children about it and why she feels compelled to create "better memories" for them.

How do brain changes, inflammation, and genetic risk factors modulate the development of PTSD or depression in patients with a history of trauma?

Charles Nemeroff, MD, PhD argues for psychiatrists to consider obtaining inflammatory marker labs on every patient that they see.

An expert talks about his interest in the mind’s relationship to the GI tract, some basics of what bacterial gut/brain communication is, and the evolutionary biology theories behind it.

What are the major cortical networks we are trying to change with TMS? Where will TMS fit into psychiatry in the next decade? These questions and more are addressed in this podcast.

An expert Q&A about the experience of TMS treatment and the future of neuromodulation as it transitions from research to practice.

It’s an FDA approved technology, but what exactly is TMS and why should you be aware of it?

Psyched! A new podcast series begins with with renowned ethics expert and Chair of the DSM Steering Committee for APA, Dr. Paul Appelbaum.

Experts discuss positive computing, an emerging field at the intersection of mental health and technology.

An expert discusses ADHD in patients over 50.

A podcast on the role of randomized controlled trials in mobile mental health research.

Dead into a wall of wind, they cliff jump with parabolic wings curled over pilots cradled in goose down and canvas.

The Chair of the Scientific Program Committee of APA 2016 offers an overview of the latest on depression.

Here’s an overview on the latest from the Chair of the Scientific Program Committee of APA 2016.

With now over 165,000 health care apps directly available for download today, how can psychiatrists identify which are the most helpful and which to avoid?

A podcast on new digital technologies for psychiatry.

Rates of severe mental illness in children and adolescents have dropped 16% since 1996, according to a new study. The lead author explains possible reasons for this surprising finding and concludes: "We're moving in the right direction!"

The trend toward transparent documentation has potential for many benefits, yet it remains a provocative concept for the field of psychiatry. In this podcast, Dr Helen Farrell answers several salient questions about transparency.

In this podcast, two psychiatrists discuss current clinical research and the future of treatment options for obsessive-compulsive disorder.

How does the diagnosis and treatment of substance use disorders fit into the general practice of psychiatry? Dr Laurence Westreich, President of the American Academy of Addiction Psychiatry, addresses that question in this podcast.

Dr Edward Nunes discusses the latest evidence from research studies on stimulant and cocaine dependence in this podcast.

Here: A 10-minute podcast on the spirit and principles that underlie motivational interviewing and the key skills and tools to encourage positive behavioral change.

It is absolutely essential that every person who has bipolar disorder be screened for risk factors related to metabolic syndrome and diabetes and traditional risk factors like overweight and eating habits. More in this podcast.

The lay press has focused a lot of attention on the use of ketamine as a potentially rapidly acting treatment for depression. But are psychiatrists really ready to offer ketamine as a treatment alternative for mood disorders? An expert weighs in.